MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3

被引:21
作者
Jin, Yanzhao [1 ]
Cheng, Hua [1 ]
Cao, Jiaqing [1 ]
Shen, Wei [1 ]
机构
[1] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 2, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China
关键词
colorectal cancer; microRNA; 32; oncogenic factor; OTU domain containing 3; COLORECTAL-CANCER; INVASION; EXPRESSION; STATISTICS; PROGNOSIS; GROWTH;
D O I
10.1002/jcb.28874
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer is considered as the fourth leading reason of cancer-linked deaths worldwide. However, our knowledge about its pathogenic mechanism remains inadequate. MicroRNA 32 (miR-32), a member of small noncoding RNAs, has been found vital roles in tumorigenesis. This study studied its functions and underlying mechanism in colorectal cancer. The experiment revealed the obvious upregulation of miR-32 in colorectal cancer tissues and six cancer cell lines, compared with normal tissues and cells. Moreover, miR-32 upregulation reduced cell apoptosis and promoted cell proliferation and migration, while its downregulation displayed opposite effects. Dual luciferase reporter assays proved that miR-32 bound to the 3 '-untranslated region (3 '-UTR) of OTU domain containing 3 (OTUD3), suggesting that miR-32 directly targeted OTUD3. Further experiments demonstrated that overexpression of miR-32 could reduce the expression level of OTUD3. Furthermore, OTUD3 silence promoted proliferation and motility and decreased apoptosis for HCT116 cells and restored partly miR-32-mediated cell proliferation, migration, and antiapoptosis for colon cancer. Therefore, our study indicated that miR-32 enhanced cell proliferation and motility abilities, and inhibited apoptosis by directly targeting OTUD3 in colon cancer cells, which implied that miR-32 was hopeful to be a biomarker or target used for diagnosis and therapy of colon cancer.
引用
收藏
页码:18629 / 18639
页数:11
相关论文
共 30 条
[1]   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer [J].
Ambs, Stefan ;
Prueitt, Robyn L. ;
Yi, Ming ;
Hudson, Robert S. ;
Howe, Tiffany M. ;
Petrocca, Fabio ;
Wallace, Tiffany A. ;
Liu, Chang-Gong ;
Volinia, Stefano ;
Calin, George A. ;
Yfantis, Harris G. ;
Stephens, Robert M. ;
Croce, Carlo M. .
CANCER RESEARCH, 2008, 68 (15) :6162-6170
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   Adjuvant therapy for completely resected stage II colon cancer [J].
Figueredo, Alvaro ;
Coombes, Megan E. ;
Mukherjee, Som .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03)
[5]   Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer [J].
Gao, Xian Hua ;
Yu, Guan Yu ;
Gong, Hai Feng ;
Liu, Lian Jie ;
Xu, Yi ;
Hao, Qiang ;
Liu, Peng ;
Liu, Zhi Hong ;
Bai, Chen Guang ;
Zhang, Wei .
SCIENTIFIC REPORTS, 2017, 7
[6]  
HONGCHANG L, 2016, CHINESE J CELL BIOL, V17, P1169
[7]   miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo [J].
Hu, Gui ;
Chen, Daojin ;
Li, Xiaorong ;
Yang, Kaiyan ;
Wang, Hongxian ;
Wu, Wei .
CANCER BIOLOGY & THERAPY, 2010, 10 (02) :190-197
[8]   MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/β-Catenin Pathway by Targeting DKK2 [J].
Kawakita, Akiko ;
Yanamoto, Souichi ;
Yamada, Shin-ichi ;
Naruse, Tomofumi ;
Takahashi, Hidenori ;
Kawasaki, Goro ;
Umeda, Masahiro .
PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (02) :253-261
[9]   miR-223 promotes colon cancer by directly targeting p120 catenin [J].
Liu, Liwei ;
Zhang, Chao ;
Li, Xiyu ;
Sun, Wenjia ;
Qin, Shenghui ;
Qin, Lingzhi ;
Wang, Xi .
ONCOTARGET, 2017, 8 (38) :63764-63779
[10]  
Madhavan Dharanija, 2013, Frontiers in Genetics, V4, P116, DOI 10.3389/fgene.2013.00116